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Abstract Recent advances in tissue engineering
have led to potential new strategies, especially decel-
lularization protocols from natural tissues, for the
repair, replacement, and regeneration of intervertebral
discs. This study aimed to validate our previously
reported method for the decellularization of annulus
fibrosus (AF) tissue and to quantify potentially
antigenic a-Gal epitopes in the decellularized tissue.
Porcine AF tissue was decellularized using different
freeze–thaw temperatures, chemical detergents, and
incubation times in order to determine the optimal
method for cell removal. The integrity of the decel-
lularized material was determined using biochemical
and mechanical tests. The a-Gal epitope was quanti-
fied before and after decellularization. Decellulariza-
tion with freeze–thaw in liquid nitrogen, an ionic
detergent (0.1% SDS), and a 24 h incubation period
yielded the greatest retention of GAG and collagen
relative to DNA reduction when tested as single
variables. Combined, these optimal decellularization
conditions preserved more GAG while removing the
same amount of DNA as the conditions used in our
previous study. Components and biomechanical prop-
erties of the AF matrix were retained. The decellular-
ized AF scaffold exhibited suitable immune-
compatibility, as evidenced by successful in vivo
remodeling and a decrease in the a-Gal epitope. Our
study defined the optimal conditions for decellular-
ization of porcine AF tissues while preserving the
biological composition and mechanical properties of
the scaffold. Under these conditions, immunocompat-
ibility was evidenced by successful in vivo remodeling
and reduction of the a-Gal epitope in the decellular-
ized material. Decellularized AF scaffolds are poten-
tial candidates for clinical applications in spinal
surgery.
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Intervertebral disc herniation is a common cause of
severe lower back pain and disability. The available
surgical treatments, including discectomy and spinal
fusion, are primarily palliative and are meant to
eliminate pain in the short term. They neither repair
the disc nor restore the normal biological and
mechanical properties of the spine. Such procedures
can limit mobility and may even further alter the
biomechanics of the spine, leading to further degen-
eration of adjacent segments. Thus, new strategies for
treating damaged intervertebral discs are needed.
Recent advances in tissue engineering present poten-
tial new strategies to repair, replace, or regenerate
degenerative discs (Mercuri et al. 2011; Schek et al.
2011; Yang et al. 2009).
The intervertebral disc (IVD) provides a cushion
between the vertebrae, protecting them from com-
pression and other stress. Each disc comprises a soft
center (the nucleus pulposus) surrounded by a tough
outer wall of collagen and proteoglycans (the annulus
fibrosus). Tears and fissures of the annulus fibrosis
(AF) due to decreased integrity of the extracellular
matrix or traumatic injury result in protrusion of the
nucleus pulposus (NP). The low vascularity and low
cellularity of the AF limit its intrinsic healing capacity,
as with articular cartilage (Bron et al. 2009; Mwale
et al. 2011). Treatments to repair such herniation
without discectomy require AF repair that is suitable to
withstand the intradiscal pressure (Guterl et al. 2013).
Direct suture of the AF is technically very demanding
due to limited space and potential injury to the
proximal neurological structures (Guterl et al. 2013).
Implants for closing the damaged AF are commer-
cially available, but these do not prevent AF degen-
eration or maintain the biological AF structure in
ensuing years (Bron et al. 2009; Chan and Gantenbein-
Ritter 2012). Materials that approximate the extracel-
lular matrix (ECM) of the AF, a key contributor to its
high strength, are thus highly attractive for such repair.
One tissue engineering strategy for developing
biomaterials is to decellularize xenogeneic tissues by
removing immunogenic cells. This method has been
successfully used to develop biomaterials for use in
cartilage, the meniscus, ligaments, and tendons, with
impressive results (Gilbert et al. 2006, 2009; Stone
et al. 2007; Wu et al. 2014; Xu et al. 2014).
Xenogeneic and allogeneic cellular antigens are
recognized as foreign by the host, thereby inducing
an inflammatory response or an immune-mediated
rejection of the tissue. However, ECM components
such as collagens, laminins, and polysaccharides, are
highly conserved among species and are tolerated well
even by xenogeneic recipients (Gilbert et al. 2006),
(Gilbert 2012). The goal of a decellularization proto-
col is to remove all cellular and nuclear materials to
prevent immune and inflammatory reactions while
minimizing any adverse effect on the composition,
biological activity, and mechanical integrity of the
remaining ECM. When properly processed to remove
cellular antigens that can induce immune rejection
without damaging the ECM, ECM scaffolds can serve
as potent sources of cues that promote constructive
remodeling of tissue after injury or degeneration.
We previously reported a preliminary method for
decellularizing porcine AF to yield a biological
scaffold for use in human AF defect substitution
(Wu et al. 2014). Our method produced a scaffold with
low DNA content that retained most of the original
biological composition and properties, with some loss
of glycosaminoglycan (GAG). The present study
aimed to manipulate several protocol variables in this
method to determine conditions that would maximize
retention of the scaffold components collagen and
GAG while minimizing the DNA content. A sec-
ondary objective was to determine the biochemical
and biomechanical properties of the acellular AF
scaffold and to preliminarily evaluate its biocompat-
ibility using a-Gal epitope quantification, in vitro




This study used xenogeneic tissue to facilitate tissue
sourcing. Fresh porcine lumbar spines were obtained
en bloc from a local abattoir (Taoyuan County,
Taiwan) within 2 h post-mortem. The AF tissue was
harvested from the IVD by gently excising and
washing in phosphate-buffered saline (PBS) to remove
excess blood. To preclude contamination by the
surrounding tissue and NP, the outermost and inner-
most layers of the AF were carefully removed.
Samples were then placed in neutral buffered formalin
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for histologic analysis or frozen and stored in PBS-
moistened filter paper at -20 C.
Comparison of decellularization methods
by biochemical assays
Protocol 1: Freeze–thaw in -80 C versus liquid
nitrogen (-196 C)
This decellularization method was a modification of
the method of Booth et al. (2002), Stapleton et al.
(2008). Briefly, the AF samples were randomly
divided into two groups (n = 6) and decellularized
by exposing the tissue to freeze–thaw. Porcine AF was
either frozen at -80 C for 22 h (Group A), or in
liquid nitrogen (-196 C) for 22 h (Group B), and
then thawed in an incubator at 37 C for 2 h. Samples
were then incubated with agitation in hypotonic buffer
(10 mM tris–HCl, pH 8.0) with 0.1% EDTA and
protease inhibitors (aprotinin 10 KIU/mL; Sigma,
USA) at 37 C for 24 h, then in 0.1% sodium dodecyl
sulfate (SDS, Wako, Japan) at 45 C for 24.
After washing, the samples were incubated in
deoxyribonclease (DNase 50U/mL; Sigma, USA) and
ribonuclease (RNase 1U/mL; Sigma, USA) in Tris
buffer (50 mM tris–HCl, 10 mMmagnesium chloride,
and 50 mg/mL bovine serum albumin at pH 7.5) for
3 h at 37 C with gentle agitation. The tissues were
then washed three times in PBS at 37 C for 8 h. Fresh
porcine AF samples (controls) were stored at-20 C.
All AF samples were then evaluated by biochemical
assay (sulfated glycosaminoglycan assay, hydrox-
yproline assay, and DNA assay, detailed methods are
described later) to compare AF properties between
tissues treated with and without decellularization.
Protocol 2: 0.1% SDS versus 1% Triton x-100
Freeze–thaw in liquid nitrogen was used, as it resulted
in more effective decellularization than did freeze–
thaw at -80 C. The AF samples were randomly
divided into C and D groups (n = 6), and all samples
were freeze–thawed in liquid nitrogen and then
incubated in a hypotonic buffer at 37 C for 24 h.
The group C samples were then decellularized in tris–
HCl buffer containing 0.1% SDS, 0.1% EDTA, and 10
KIU/mL aprotinin at 4 C for 24 h. The group D
samples were decellularized in tris–HCl buffer with
1% Triton X-100 (Sigma, USA), 0.1% EDTA and 10
KIU/ml aprotinin at 4 C for 24 h. The samples were
washed and incubated with DNase and RNase in Tris
buffer, washed for 8 h in PBS, and evaluated by
biochemical assay as described in Protocol 1.
Protocol 3: Comparison between decellularization
times of 24 versus 48 vs. 72 h using 0.1% SDS
Freeze–thaw in liquid nitrogen followed by treatment
with 0.1% SDS showed better decellularization results
compared to 1% Triton X-100, and was therefore
selected as the optimal method. AF samples were
randomly divided into 3 groups (n = 6/group),
freeze–thawed in liquid nitrogen and then incubated
in a hypotonic buffer at 37 C for 24 h. The samples
were then decellularized in tris–HCl buffer containing
0.1% SDS, 0.1% EDTA and 10 KIU/mL aprotinin at
4 C for 24 h (group E), 48 h (group F), or 72 h (group
G). The samples were washed, incubated with DNase
and RNase in Tris buffer, washed for 8 h in PBS and
evaluated by biochemical assay as described in
Protocol 1.
Optimal decellularization method
Based on our optimization data, we treated AF
samples (n = 10) by freeze–thaw in liquid nitrogen,
incubation in a hypotonic buffer at 37 C for 24 h, and
decellularization in 0.1% SDS, 0.1% EDTA and 10
KIU/mL aprotinin at 4 C for 24 h. After washing,
samples treated with DNase and RNase, stored, and
assayed as described in the previous section.
Biochemical assays
Sulfated glycosaminoglycan assay
The proteoglycan content of the tissue was determined
by measuring the amount of sulfated glycosaminogly-
cans in the papain-digested tissue using the 1,9-
dimethylmethylene blue (DMMB) dye binding assay
and spectrophotometry (Farndale et al. 1986). The AF
tissue specimens (n = 6) were first lyophilized (dry
weight, 50 mg) and then digested in papain buffer
(250 lL papain in PBS at pH 6.0 with 150 mM
sodium chloride, 55 nM sodium citrate, 5 mM cys-
teine-HCl, and 5 mM Na2EDTA) at 60 C for 12 h.
The supernatant fluid was measured at 530 nm using




The collagen content was quantified using a commer-
cially available assay kit (hydroxyproline assay kit,
BioVision, Milpitas, CA, USA) (Zhang et al. 2012).
The AF specimens (n = 6) were first lyophilized and
then hydrolyzed in 6 M HCl at 120 C for 3 h and
neutralized using NaOH. The hydroxyproline content
was determined using the chloramine-T/Ehrlich’s
reagent assay and spectrophotometry at 550 nm. The
concentration of hydroxyproline was then calculated
by interpolation from a hydroxyproline standard
curve.
DNA assay
The residual cells were determined by DNA assay
using the ReliaPrep gDNA Tissue Miniprep System
(Promega, Fitchburg, WI, USA) (Rabelo-Goncalves
et al. 2014). The DNA was extracted from both native
and decellularized AF. Six AF specimens (wet weight,
25 mg) were used. The DNA was extracted using a
DNA isolation kit and then quantified according to
standard protocols by measuring the absorbance at
260/280 nm using a spectrophotometer (NanoDrop
ND 1000; Thermo Scientific, Waltham, MA, USA).
Histology
Tissue specimens (n = 5) were fixed in neutral
buffered formalin for 48 h, then embedded in paraffin
wax and sectioned at 6 lm thickness using a micro-
tome. Samples were characterized histologically by
hematoxylin and eosin staining (H&E, Bios Europe,
Skelmersdale, UK) to evaluate cellular content and the
AF structure and by Masson’s Trichrome Staining
(MT staining) to visualize collagen distribution and
orientation. Glycosaminoglycans (GAGs) were visu-
alized by periodic acid-schiff (PAS) staining.
Scanning electron microscopy (SEM)
Fresh-frozen AF and the decellularized AF scaffolds
prepared by optimal decellularization method (OC)
were harvested and fixed in 4% paraformaldehyde
(wt/vol) for 2 days. The samples (n = 5) underwent
sequential dehydration and were sputter-coated with
gold (5 nm thick) to impart electrical conductivity.
The specimens were then evaluated and imaged using
SEM (JSM 5600, JEOL, Tokyo, Japan) to evaluate the
ultra-structure of the AF surfaces.
Compression (indentation) test
Compression tests were conducted using a Universal
Testing Machine. Uni-axial compression tests were
performed at room temperature (26 C) and 60%
relative humidity. The constant deformation rate was
set at 0.1 mm/sec for all materials examined (n = 6).
Force and deformation (changes in length) were
recorded electronically, and the resulting stress–strain
compression curves were constructed.
a-Gal ELISA test sample processing
Native AF and decellularized AF scaffolds (OC) were
thoroughly rinsed in ice-cold PBS (0.02 M, pH
7.0–7.2) for a brief washing and weighing before
homogenization. The tissues were minced into small
pieces and homogenized in a PBS using a glass
homogenizer on ice. The resulting suspension was
subjected to ultrasonication to further break down cell
membranes and then centrifuged for 15 min at
15009g. The supernatant was then removed and
assayed as follows.
Quantification of a-Gal content
The ELISA test for a-Gal was carried out as
previously reported (Naso et al. 2011, 2013) using a
commercially available assay kit (Alpha-Galactosyl
ELISA Kit, BlueGene Biotech, Shanghai, China).
Microtitre-plate wells pre-coated with antibody were
loaded with 100 lL of supernatant derived from
native AF tissue (n = 8) and decellularized AF tissue
(n = 8). Conjugate (50 lL) was then added to each
well, and the mixture was incubated for 1 h at 37 C in
darkness. The micro-titer plate was washed 5 times;
after the final wash, the plate was inverted and blotted
dry.
After drying, 100 lL of horseradish peroxidase
substrate buffer was added to each well and incubated
for 15 min at room temperature in darkness. Stop
solution (50 lL) was then added to each well, and the
Optical Density (OD) was immediately read at
450 nm using a micro-titer plate reader.
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Cytotoxicity of decellularized AF in a trans-well
insert model
Samples of decellularized AF scaffolds (OC) were
prepared and placed at the bottom of trans-well insert
wells before cytotoxicity testing. The trans-wells used
in this study were 24 mm in diameter, with a
membrane pore size of 0.4 lm (Costar, Transwell,
Corning, NY, USA). The trans-wells were placed onto
24-well culture plates, seeded with NIH3T3 fibrob-
lasts (3 9 103 cells/well), and incubated for 1 or
2 days. For each sample, 5 wells were prepared.
For controls, the cells were cultured in 24-well
plates with trans-well inserts but without AF tissue.
After co-culture, the insert wells were removed.
Viability of the target NIH3T3 fibroblasts was mea-
sured using 3-(4,5-dimethylthiazol-2-yl)-5-(3-car-
boxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium
(MTS, Promega) according to the manufacturer’s
instructions.
In vivo immuno-compatibility study
The host response to decellularized AF was assessed
in 6 male Wistar rats (300–350 g), and all experiments
were conducted according to the principles and
procedures described by the Institutional Animal Care
and Use Committee of National Taiwan University.
Briefly, two non-contiguous coccygeal intervertebral
discs were selected for the study. After anesthesia, a
longitudinal incision was created over the tail region,
and the posterior surface of the coccygeal interverte-
bral discs was exposed by anatomic dissection along
the skin incision. Care was taken not to interrupt the
outer annular fibers of the disc. A 1 9 1 mm rectan-
gular excision was made through the annulus fibrosus
and into the nucleus pulposus.
The two non-contiguous discs were delegated to the
control group (box incision only) and the repair group,
in which the box defect was implanted with decellu-
larized AF scaffold (sterilized) and sutured using 6-0
non-absorbable polypropylene. In each group, rats
were further divided into 2 subgroups, with 2 healing
times, 7 and 14 days. The intervertebral disc levels of
the annular incisions were randomized from animal to
animal to diminish any level-specific differences.
Upon euthanization, the discs were harvested and
examined histologically for signs of inflammatory
response (H&E staining) and ECM production (MT
and PAS staining).
Statistical analysis
All data are presented as the mean ± standard devi-
ation (SD). Analysis of variance (ANOVA) was
implemented to test differences between 3 or 4 groups,
and independent t-tests were carried out to compare 2
groups. All statistics were two-sided, and p\ 0.05
was considered statistically significant. Statistical
analyses were performed using SPSS statistical soft-
ware forWindows (version 22.0, IMB Corp., Armonk,
NY).
Results
Comparison of decellularization methods
by biochemical assays
The quantities of decellularized AF components under
various freeze–thaw temperatures, detergents, and
times are summarized in Table 1. The levels of
ECM components were lower after decellularization
in liquid nitrogen (-196 C) than in control AF
samples. However, samples decellularized with liquid
nitrogen had a higher content of GAG, collagen and
DNA compared to those decellularized at -80 C.
More GAG and collagen content was preserved by
decellularization in 0.1% SDS than in Triton X-100.
However, the DNA content in the 0.1% SDS group
was lower than in the Triton X-100 group and was
therefore superior to Triton X-100 for AF
decellularization.
The DNA content was significantly lower after 24 h
of decellularization and effectively removed after
72 h. However, extension of the decellularization time
resulted in greater losses of GAG and collagen. Thus,
the ideal decellularization time was determined to be
24 h.
The optimal decellularization conditions therefore
included liquid nitrogen, 0.1% SDS and a decellular-
ization period of 24 h. There were no differences in
GAG and collagen content between AF treated with
the optimal decellularized method and the native AF
group, while the DNA content of the decellularized
samples was 85.7% lower than that of the control




On H&E staining, native AF samples showed many
cells to be embedded in the matrix (Fig. 1a). In tissues
subject to decellularization under optimal conditions
(OC), cellular material was rare on H&E staining
(Fig. 1b). On the other hand, MT staining revealed
abundant collagen fibrils visible in both native and
decellularized AF (OC) without obvious changes in
morphology or distribution (Fig. 2). Many cells were








Fresh AF (n = 6) 107.07 ± 7.24 102.15 ± 9.93 46.31 ± 5.92
Freeze–thaw in -80 C (n = 6) 94.03 ± 7.18a 93.62 ± 5.26a 10.38 ± 1.19a
Freeze–thaw in -196 C liquid nitrogen refrigeration (n = 6) 99.57 ± 7.70a,b 101.75 ± 6.97a,b 12.03 ± 2.52a,b
Detergents
Fresh AF (n = 6) 150.97 ± 4.60 117.68 ± 7.40 73.22 ± 5.43
Decellularized in SDS (n = 6) 142.85 ± 4.9a 108.58 ± 11.58a 12.34 ± 3.14a
Decellularized in Triton X-100 (n = 6) 127.08 ± 8.45a,c 100.79 ± 10.86a,c 25.59 ± 7.04a,c
Decellularization time
Fresh AF (n = 6) 96.09 ± 2.88 120.94 ± 4.33 46.31 ± 5.92
Decellularization for 24 h (n = 6) 82.77 ± 6.17a 109.72 ± 2.96a 11.07 ± 2.17a
Decellularization for 48 h (n = 6) 47.49 ± 6.25a,d 94.18 ± 3.28a,d 9.16 ± 2.11a
Decellularization for 72 h (n = 6) 14.44 ± 2.90a,d,e 89.80 ± 5.85a,d,e 4.23 ± 1.34a
Optimal decellularization methods (ODM)
Fresh AF (n = 10) 121.63 ± 5.66 153.63 ± 17.14 63.55 ± 3.71
Optimal decellularization methods (n = 10) 114.77 ± 10.61 151.73 ± 12.62 9.10 ± 2.20a
Data are presented as mean ± standard deviation, and tested by analysis of variance for comparisons among 3 or 4 groups, or by
independent t test for comparison between 2 groups
AF annulus fibrosus, GAG glycosaminoglycans, SDS sodium dodecyl sulfate
a Significantly different from Fresh AF group, p\ 0.05
b Significantly different from -80 C group, p\ 0.05
c Significantly different from SDS group, p\ 0.05
d Significantly different from 24 h group, p\ 0.05
e Significantly different from 48 h group, p\ 0.05
Fig. 1 Histology of annulus fibrosus (AF) with H&E stain. Cellular material is a clearly embedded in the matrix and b rare-to-absent in
decellularized AF. Both 940 magnification
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seen scattered among collagen fibers in native AF
samples (Fig. 2a).
PAS staining showed that both native AF and
decellularized AF (OC) were rich in proteoglycans.
Scaffolds prepared by different protocols showed
differences in biochemical assays, although histologic
assay showed no significant differences, suggesting
that the decellularization process did not destroy the
microstructure (Fig. 3).
Scanning electron microscopy (SEM) analysis
Scanning electron microscopy (SEM) revealed small
pore-like structures on the surface of both native and
decellularized AF surfaces (OC), confirming the
retention of pore-like structures after decellularization
(Fig. 4).
Biomechanical testing
Using force and deformation results, stress–strain
compression curves were constructed and Young’s
modulus was obtained (Fig. 5). Compression testing
showed no difference between native and decellular-
ized AF scaffolds (p[ 0.05, Student’s t test).
Cytotoxicity assay
In vitro toxicity studies of control and decellularized
AFwere conducted using theMTS assay with NIH3T3
cells. At all time points, OD values did not differ
between the 2 groups (p[ 0.05), indicating that the
decellularized AF was not cytotoxic (Fig. 6).
In vivo immuno-compatibility study
After 7 days of healing, the annulus defect in all
samples of both the control and repair groups was
covered by scar tissue and populated mostly by
mononuclear cells (Fig. 7). MT and PAS staining
revealed that the densities of collagen and GAG were
higher in the repair group than in controls. There was
increased organization of collagen distribution in the
repair group compared to the control group.
Fig. 2 a Fresh and b decellularized annulus fibrosus stained with Masson’s Trichrome (MT) staining. 940 magnification
Fig. 3 a Fresh and b decellularized annulus fibrosus stained with Periodic acid-schiff (PAS) staining. 940 magnification
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After 14 days of healing, a decrease in mononu-
clear cells was noted in all samples (Fig. 8). MT and
PAS staining revealed that the density of collagen and
GAG was still higher in the repair group than in the
control group. The density of collagen and GAG was
also higher after 14 days of healing than after 7 days.
Tissue remodeling was evident at multiple sites, and
mononuclear and fibroblast-like cells were found deep
within the matrix in both groups.
Quantification of a-Gal content
The a-Gal content was significantly lower in decellu-
larized than in control AF (p\ 0.001). Treatment of
AF tissues under optimal decellularization conditions
resulted in apparent removal of the a-Gal xeno-
antigen (Fig. 9).
Discussion
This study investigated optimization of decellulariza-
tion conditions on AF tissue to identify conditions that
maximize retention of ECM properties in the resulting
AF scaffold while minimizing toxicity and immuno-
genic factors such as DNA. Our data suggested that
samples decellularized in liquid nitrogen had higher
GAG, collagen, and DNA content compared to those
decellularized at -80 C. More GAG and collagen
were preserved by decellularization in 0.1% SDS than
in Triton X-100, with lower DNA content remaining.
A decellularization time of 24 h maximized GAG and
collagen preservation while decreasing DNA content
relative to that of controls. Results of a-Gal epitope
quantitation, in vitro cytotoxicity assays, and an
in vivo immuno-compatibility study all showed that
decellularization with liquid nitrogen in the presence
of 0.1% SDS for 24 h greatly reduced the immuno-
genicity of porcine AF.
A number of studies have investigated decellular-
ization protocols using different chemical, physical,
and enzymatic methods (Dahl et al. 2003; Hongo et al.
2008; Huang et al. 2011; Rieder et al. 2004; Woods
and Gratzer 2005). Since any processing steps
intended to remove cells could alter the native three-
dimensional architecture of the ECM, the goal of most
Fig. 4 Scanning electron microscopy (SEM) images of annulus
fibrosus (AF). a Fresh AF has pore-like structures, 9100
magnification. b Decellularized AF has confirmed retention of
pore-like structures on the AF surface, 9100 magnification.




decellularization processes is to minimize disruption,
thereby retaining the native mechanical and biological
properties of the material. Preliminary studies
indicated that decellularization of AF is complex due
to its dense collagenous and GAG-rich nature (Gilbert
2012).
Since rapid freezing of a tissue causes formation of
intracellular ice crystals, disruption of cell membranes
and cell lysis, we compared -80 C versus liquid
nitrogen for physical decellularization. This procedure
was followed by chemical treatment to remove
cellular material from the tissue. Our data showed
that decellularization using liquid nitrogen yielded
higher amounts of GAG and collagen compared to
freeze–thaw.
Based on their ability to solubilize the cell mem-
brane, ionic detergents such as SDS and non-ionic
detergents such as Triton X-100 have been widely
studied for tissue decellularization (Crapo et al. 2011;
Gilbert et al. 2006). Non-ionic detergents are some-
times more desirable since they have the least impact
on protein structure due to their lack of ionic charge,
while ionic detergents are considered to be harsher to
tissues, with greater disruption of protein structure and
loss of matrix components (Gilbert 2012). Early
studies reported that SDS was more effective than
Triton X-100 for removing nuclei from dense tissues
and organs while preserving tissue mechanics (Lump-
kins et al. 2008; Nakayama et al. 2010; Pridgen et al.
2011). However, the effectiveness of decellularization
using these agents remains unclear due to the varia-
tions between different studies in concentrations,
temperatures, and times of detergent use. Our present
data showed higher retention of collagen and GAG
with 0.1% SDS compared to Triton X-100. Decellu-
larization for 72 h in 0.1% SDS effectively removed
DNA. However, since there was a higher loss of GAG
and collagen compared to the 24 h decellularization
protocol, the optimal decellularization time was
determined to be 24 h. Our final optimized decellu-
larization method therefore included the use of liquid
nitrogen, an ionic detergent (0.1% SDS), and a 24 h
incubation period, which yielded the greatest retention
of GAG and collagen relative to DNA reduction.
We evaluated the effects of decellularization on the
biochemical and biomechanical properties of the
resulting scaffold, and whether our decellularization
process enabled the retention of collagen and GAG
content close to that of the native AF. Our data showed
abundant collagen fibrils in both native and decellu-
larized AF, without gross evidence of damage and
distribution. There was also no significant difference
Fig. 5 Biomechanical testing of annulus fibrosus. a Stress–
strain compression curves. b Young’s modulus
Fig. 6 Cytotoxicity studies of the control and decellularized
annulus fibrosus (AF). There were no statistically significant
differences between decellularized AF and negative control.
Open bar negative control; Closed barDAF (decellularized AF)
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in collagen content between native and decellularized
AF. Our present data showed that 5.6% of GAG was
lost during processing, which was an improvement
over our previous protocol, which resulted in a 15.9%
loss of GAG (Wu et al. 2014).
Tissues were extensively washed in PBS at the
end of the protocol since the chemicals and enzymes
used for decellularization can be toxic to host cells
upon in vivo implantation if they remain within the
tissue after treatment. Simple in vitro cytotoxicity
tests to examine the biocompatibility of decellular-
ized AF scaffolds indicated that any residual cyto-
toxic reagents were successfully removed by the
washing procedure. In addition, our immune-com-
patibility data showed that the annulus defects in
both control and repair groups in the in vivo study
were covered by scar tissue and populated mostly by
mononuclear cells on day 7, although the densities of
collagen and GAG were higher in the repair group
than in controls. Increased organization of collagen
distribution in the repair group compared to the
control group suggested efficient tissue remodeling
in the repair group. Mononuclear cells decreased
with time in all samples, while fibroblast-like cell
infiltration of the matrix was a key feature of the
tissue remodeling observed.
Fig. 7 In vivo immuno-compatibility studies at 7 days. a Con-
trol group with H&E stain, 940 magnification. b Repair group
with H&E stain, 940 magnification. c Control group with MT
staining, 940 magnification. d Repair group with MT staining,
940 magnification. e Control group with PAS staining, 940




Devising a successful strategy for AF repair
requires a clear understanding of the functional
biomechanics of the intervertebral disc. Intervertebral
discs serve to support large spinal loads involving
combinations of tension, torsion, compression, and
bending. Therefore, AF repair materials must with-
stand the high stresses generated by spinal motion (Jin
et al. 2013). Biomechanical testing of the decellular-
ized AF demonstrated no significant difference in
Young’s modulus, further indicating satisfactory
preservation of the biomechanical properties of the
native tissue.
Pig-to-human xeno-transplantation offers a poten-
tial solution to the shortage of organs for
transplantation. However, xeno-transplantation from
pigs to humans induces hyper-acute rejection because
the a-Gal epitope, expressed in both pigs and humans,
is the major antigen inducing complement-mediated
cell lysis via human antibodies. Efforts to eliminate
the a-Gal epitope from xenografts include (1) the
production of alpha1,3-galactosyltransferase knock-
out pigs (Milland et al. 2005; Puga Yung et al. 2012),
(2) treatment of xenogeneic tissue with a-galactosi-
dase (Goncalves et al. 2005; Choi et al. 2012), and (3)
introduction of human complement regulatory protein
genes into pig cells. Although the cloning of knockout
pigs lacking a-Gal epitopes has eliminated the anti-
Gal immune barrier to xeno-transplantation, this
Fig. 8 In vivo immuno-compatibility studies at 14 days.
a Control group with H&E stain, 940 magnification. b Repair
group with H&E stain,940 magnification. c Control group with
MT staining, 940 magnification. d Repair group with MT
staining,940 magnification. eControl group with PAS staining,




process is costly. Modification of a-Gal on the cell
surface has also been attempted using decellulariza-
tion. Of the various detergents tested, only SDS is
reported to remove these xeno-antigens (Goncalves
et al. 2005). Our data suggested that the use of SDS
during the decellularization process removed a-Gal
xeno-antigens. To the best of our knowledge, our
study is the first to report quantification of the a-Gal
epitope in decellularized porcine AF tissues.
Residual a-Gal epitopes have been found in
commercial bioprostheses of porcine heart valves,
SIS-ECM (small intestinal submucosa—extracellu-
lar matrix) (Naso et al. 2013; Zheng et al. 2005).
Non-a-Gal epitopes can also be immunogenic (Lam
et al. 2004; Chen et al. 2005). Previous studies
investigating the role of the a-Gal epitope in the host
immune response to SIS-ECM reported that the
immuno-modulatory effect of the a-Gal epitope did
not adversely affect the in vivo remodeling of
xenogeneic ECM (Raeder et al. 2002; Daly et al.
2009). Long-term production of anti-non-Gal anti-
bodies against porcine xeno-antigens in human
recipients were reported to contribute to a low-level
inflammatory process in dense xenografts (Stone
et al. 2007).
Most commercially available biologic scaffold
materials contain trace amounts of remnant DNA,
which is typically present as small fragments and
subject to degradation via enzymatic breakdown
(Gilbert et al. 2009; Zheng et al. 2005). Although the
remaining DNA fragments and a-Gal epitopes are
known to stimulate an immune reaction, it is possible
that a threshold amount of material is required to
adversely affect the remodeling response (Badylak
and Gilbert 2008). It is unlikely that any combination
of methods will remove 100% of all cell xeno-antigens
from a tissue or organ. However, methods that remove
most or all of the visible cellular material likely result
in biologic scaffold materials that are safe for
implantation (Gilbert et al. 2006). Our future work
will aim to optimize cell seeding and test the
decellularized AF scaffold in a functional large-
animal model of disc repair. These studies will
determine the in vivo regenerative capacity of porcine
AF scaffolds over the long term.
Conclusions
A porcine decellularization method including freeze–
thaw in liquid nitrogen, an ionic detergent (0.1%
SDS), and a 24 h incubation period resulted in an AF
scaffold which retained the necessary components of
the AF matrix, the ultrastructure of the ECM, and the
biomechanical properties of the AF. This decellular-
ization protocol also greatly reduced the immuno-
genicity of porcine AF. The scaffold was therefore
biocompatible and is a potential candidate for clinical
use.
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fibrosus tissues with the decellularization method resulted in the




Badylak SF, Gilbert TW (2008) Immune response to biologic
scaffold materials. Semin Immunol 20:109–116
Booth C, Korossis SA, Wilcox HE, Watterson KG, Kearney JN,
Fisher J, Ingham E (2002) Tissue engineering of cardiac
valve prostheses I: development and histological charac-
terization of an acellular porcine scaffold. J Heart Valve
Dis 11:457–462
Bron JL, HelderMN,Meisel HJ, Van Royen BJ, Smit TH (2009)
Repair, regenerative and supportive therapies of the
annulus fibrosus: achievements and challenges. Eur Spine J
18:301–313
Chan SC, Gantenbein-Ritter B (2012) Intervertebral disc
regeneration or repair with biomaterials and stem cell
therapy–feasible or fiction? Swiss Med Wkly 142:w13598
Chen G, Qian H, Starzl T, Sun H, Garcia B, Wang X, Wise Y,
Liu Y, Xiang Y, Copeman L, Liu W, Jevnikar A, Wall W,
Cooper DK, Murase N, Dai Y, Wang W, Xiong Y, White
DJ, Zhong R (2005) Acute rejection is associated with
antibodies to non-Gal antigens in baboons using Gal-
knockout pig kidneys. Nat Med 11:1295–1298
Choi SY, Jeong HJ, Lim HG, Park SS, Kim SH, Kim YJ (2012)
Elimination of alpha-gal xenoreactive epitope: alpha-
galactosidase treatment of porcine heart valves. J Heart
Valve Dis 21:387–397
Crapo PM, Gilbert TW, Badylak SF (2011) An overview of
tissue and whole organ decellularization processes. Bio-
materials 32:3233–3243
Dahl SL, Koh J, Prabhakar V, Niklason LE (2003) Decellular-
ized native and engineered arterial scaffolds for trans-
plantation. Cell Transpl 12:659–666
Daly KA, Stewart-Akers AM, Hara H, Ezzelarab M, Long C,
Cordero K, Johnson SA, Ayares D, Cooper DK, Badylak
SF (2009) Effect of the alphaGal epitope on the response to
small intestinal submucosa extracellular matrix in a non-
human primate model. Tissue Eng Part A 15:3877–3888
Farndale RW, Buttle DJ, Barrett AJ (1986) Improved quanti-
tation and discrimination of sulphated glycosaminoglycans
by use of dimethylmethylene blue. Biochem Biophys Acta
883:173–177
Gilbert TW (2012) Strategies for tissue and organ decellular-
ization. J Cell Biochem 113:2217–2222
Gilbert TW, Sellaro TL, Badylak SF (2006) Decellularization of
tissues and organs. Biomaterials 27:3675–3683
Gilbert TW, Freund JM, Badylak SF (2009) Quantification of
DNA in biologic scaffoldmaterials. J SurgRes 152:135–139
Goncalves AC, Griffiths LG, Anthony RV, Orton EC (2005)
Decellularization of bovine pericardium for tissue-engi-
neering by targeted removal of xenoantigens. J Heart Valve
Dis 14:212–217
Guterl CC, See EY, Blanquer SB, Pandit A, Ferguson SJ,
Benneker LM, Grijpma DW, Sakai D, Eglin D, Alini M,
Iatridis JC, Grad S (2013) Challenges and strategies in the
repair of ruptured annulus fibrosus. Eur Cells Mater
25:1–21
Hongo M, Gay RE, Hsu JT, Zhao KD, Ilharreborde B, Berglund
LJ, An KN (2008) Effect of multiple freeze–thaw cycles on
intervertebral dynamic motion characteristics in the por-
cine lumbar spine. J Biomech 41:916–920
Huang H, Zhang J, Sun K, Zhang X, Tian S (2011) Effects of
repetitive multiple freeze–thaw cycles on the biomechan-
ical properties of human flexor digitorum superficialis and
flexor pollicis longus tendons. Clin Biomech 26:419–423
Jin L, Shimmer AL, Li X (2013) The challenge and advance-
ment of annulus fibrosus tissue engineering. Eur Spine J
22:1090–1100
Lam TT, Paniagua R, Shivaram G, Schuurman HJ, Borie DC,
Morris RE (2004) Anti-non-Gal porcine endothelial cell
antibodies in acute humoral xenograft rejection of hDAF-
transgenic porcine hearts in cynomolgus monkeys. Xeno-
transplantation 11:531–535
Lumpkins SB, Pierre N, McFetridge PS (2008) A mechanical
evaluation of three decellularization methods in the design
of a xenogeneic scaffold for tissue engineering the tem-
poromandibular joint disc. Acta Biomater 4:808–816
Mercuri JJ, Gill SS, Simionescu DT (2011) Novel tissue-derived
biomimetic scaffold for regenerating the human nucleus
pulposus. J Biomed Mater Res, Part A 96:422–435
Milland J, Christiansen D, Sandrin MS (2005) Alpha 1,3-
galactosyltransferase knockout pigs are available for
xenotransplantation: are glycosyltransferases still rele-
vant? Immunol Cell Biol 83:687–693
Mwale F, Masuda K, Pichika R, Epure LM, Yoshikawa T,
HemmadA, Roughley PJ, Antoniou J (2011) The efficacy of
Link N as a mediator of repair in a rabbit model of inter-
vertebral disc degeneration. Arthritis Res Ther 13:R120
Nakayama KH, Batchelder CA, Lee CI, Tarantal AF (2010)
Decellularized rhesus monkey kidney as a three-dimen-
sional scaffold for renal tissue engineering. Tissue Eng Part
A 16:2207–2216
Naso F, Gandaglia A, Iop L, Spina M, Gerosa G (2011) First
quantitative assay of alpha-Gal in soft tissues: presence and
distribution of the epitope before and after cell removal
from xenogeneic heart valves. Acta Biomater 7:1728–1734
Naso F, Gandaglia A, Bottio T, Tarzia V, Nottle MB, d’Apice
AJ, Cowan PJ, Cozzi E, Galli C, Lagutina I, Lazzari G, Iop
L, Spina M, Gerosa G (2013) First quantification of alpha-
Gal epitope in current glutaraldehyde-fixed heart valve
bioprostheses. Xenotransplantation 20:252–261
Pridgen BC,Woon CY, KimM, Thorfinn J, Lindsey D, PhamH,
Chang J (2011) Flexor tendon tissue engineering: acellu-
larization of human flexor tendons with preservation of
biomechanical properties and biocompatibility. Tissue Eng
Part C Methods 17:819–828
Puga Yung GL, Li Y, Borsig L, Millard AL, Karpova MB, Zhou
D, Seebach JD (2012) Complete absence of the alphaGal
xenoantigen and isoglobotrihexosylceramide in alpha1,3-
galactosyltransferase knock-out pigs. Xenotransplantation
19:196–206
Rabelo-Goncalves E, Roesler B, Guardia AC, Milan A, Hara N,
Escanhoela C, Almeida J, Boin I, Zeitune JM (2014)
Evaluation of five DNA extraction methods for detection of
H. pylori in formalin-fixed paraffin-embedded (FFPE) liver
tissue from patients with hepatocellular carcinoma. Pathol
Res Pract 210:142–146
Raeder RH, Badylak SF, Sheehan C, Kallakury B, Metzger DW
(2002) Natural anti-galactose alpha1,3 galactose antibod-
ies delay, but do not prevent the acceptance of extracellular
matrix xenografts. Transpl Immunol 10:15–24
Cell Tissue Bank
123
Rieder E, Kasimir MT, Silberhumer G, Seebacher G, Wolner E,
Simon P, Weigel G (2004) Decellularization protocols of
porcine heart valves differ importantly in efficiency of cell
removal and susceptibility of the matrix to recellularization
with human vascular cells. J Thorac Cardiovasc Surg
127:399–405
Schek RM,Michalek AJ, Iatridis JC (2011) Genipin-crosslinked
fibrin hydrogels as a potential adhesive to augment inter-
vertebral disc annulus repair. Eur Cells Mater 21:373–383
Stapleton TW, Ingram J, Katta J, Knight R, Korossis S, Fisher J,
Ingham E (2008) Development and characterization of an
acellular porcine medial meniscus for use in tissue engi-
neering. Tissue Eng Part A 14:505–518
Stone KR, Abdel-Motal UM,Walgenbach AW, Turek TJ, Galili
U (2007) Replacement of human anterior cruciate liga-
ments with pig ligaments: a model for anti-non-gal anti-
body response in long-term xenotransplantation.
Transplantation 83:211–219
Woods T, Gratzer PF (2005) Effectiveness of three extraction
techniques in the development of a decellularized bone-
anterior cruciate ligament-bone graft. Biomaterials
26:7339–7349
Wu LC, Chiang CJ, Liu ZH, Tsuang YH, Sun JS, Huang YY
(2014) Fabrication and properties of acellular porcine
annulus fibrosus for tissue engineering in spine surgery.
J Orthop Surg Res 9:118
XuH, Xu B, Yang Q, Li X,MaX, Xia Q, Zhang Y, Zhang C,Wu
Y, Zhang Y (2014) Comparison of decellularization pro-
tocols for preparing a decellularized porcine annulus
fibrosus scaffold. PLoS ONE 9:e86723
Yang L, Kandel RA, Chang G, Santerre JP (2009) Polar surface
chemistry of nanofibrous polyurethane scaffold affects
annulus fibrosus cell attachment and early matrix accu-
mulation. J Biomed Mater Res, Part A 91:1089–1099
Zhang L, Dong Y, Dong Y, Cheng J, Du J (2012) Role of
integrin-beta3 protein in macrophage polarization and
regeneration of injured muscle. J Biol Chem
287:6177–6186
Zheng MH, Chen J, Kirilak Y, Willers C, Xu J, Wood D (2005)
Porcine small intestine submucosa (SIS) is not an acellular
collagenous matrix and contains porcine DNA: possible
implications in human implantation. J BiomedMater Res B
Appl Biomater 73:61–67
Cell Tissue Bank
123
